Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders.
Rustgi
V K
VK
Inova Institute of Research and Education, Fairfax Hospital, Falls Church, VA 22046, USA.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000821:virology; D006566:Herpesviridae Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D011379:Prognosis; D014412:Tumor Virus Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014779:Virus Replication
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D007166:Immunosuppressive Agents